BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17251666)

  • 1. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.
    Kajiguchi M; Kondo T; Izawa H; Kobayashi M; Yamamoto K; Shintani S; Numaguchi Y; Naoe T; Takamatsu J; Komori K; Murohara T
    Circ J; 2007 Feb; 71(2):196-201. PubMed ID: 17251666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia.
    Burt RK; Testori A; Oyama Y; Rodriguez HE; Yaung K; Villa M; Bucha JM; Milanetti F; Sheehan J; Rajamannan N; Pearce WH
    Bone Marrow Transplant; 2010 Jan; 45(1):111-6. PubMed ID: 19448678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic angiogenesis using bone marrow cells].
    Ikeda U
    Masui; 2007 Nov; 56 Suppl():S6-11. PubMed ID: 18051443
    [No Abstract]   [Full Text] [Related]  

  • 5. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
    Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
    Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
    Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H;
    Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors for critical limb ischemia after autologous bone marrow implantation].
    Oda M; Kato K; Toba K; Otaki K; Kitajima T; Ikarashi N; Yanagawa T; Higashimura M; Asami F; Isoda M; Ozawa T; Moriyama M; Hirono S; Okura Y; Hanawa H; Kodama M; Aizawa Y
    J Cardiol; 2007 Oct; 50(4):235-42. PubMed ID: 17987839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic angiogenesis by autologous transplantation of bone-marrow cells in a patient with progressive limb ischemia due to arteriosclerosis obliterans: a case report].
    Hasebe H; Osada M; Kodama Y; Fujioka D; Sano K; Nakamura T; Mitsumori T; Nakamura K; Kitta Y; Ichiki Y; Obata J; Kawabata K; Yanagi M; Sano S; Takano H; Umetani K; Kugiyama K
    J Cardiol; 2004 Apr; 43(4):179-83. PubMed ID: 15125382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases.
    Kamata Y; Takahashi Y; Iwamoto M; Matsui K; Murakami Y; Muroi K; Ikeda U; Shimada K; Yoshio T; Okazaki H; Minota S
    Rheumatology (Oxford); 2007 May; 46(5):882-4. PubMed ID: 17309890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis using autologous adipose-derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study.
    Katagiri T; Kondo K; Shibata R; Hayashida R; Shintani S; Yamaguchi S; Shimizu Y; Unno K; Kikuchi R; Kodama A; Takanari K; Kamei Y; Komori K; Murohara T
    Sci Rep; 2020 Sep; 10(1):16045. PubMed ID: 32994527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
    Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
    Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients.
    Arici V; Perotti C; Fabrizio C; Del Fante C; Ragni F; Alessandrino F; Viarengo G; Pagani M; Moia A; Tinelli C; Bozzani A
    J Transl Med; 2015 Nov; 13():342. PubMed ID: 26526721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.
    Heo SH; Park YS; Kang ES; Park KB; Do YS; Kang KS; Kim DI
    Sci Rep; 2016 Jan; 6():19690. PubMed ID: 26791280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.
    Saito Y; Sasaki K; Katsuda Y; Murohara T; Takeshita Y; Okazaki T; Arima K; Katsuki Y; Shintani S; Shimada T; Akashi H; Ikeda H; Imaizumi T
    Circ J; 2007 Aug; 71(8):1187-92. PubMed ID: 17652879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease.
    Kim DI; Kim MJ; Joh JH; Shin SW; Do YS; Moon JY; Kim NR; Lim JE; Kim AK; Eo HS; Kim BS; Cho SW; Yang SH; Park CJ; Shim JS
    Stem Cells; 2006 May; 24(5):1194-200. PubMed ID: 16439614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.
    Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J
    Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiogenic cell therapy].
    Murohara T
    Nihon Rinsho; 2003 May; 61(5):871-80. PubMed ID: 12755018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic angiogenesis for patients with critical limb ischemia using autologous bone marrow cell transplantation].
    Matsubara H
    Nihon Naika Gakkai Zasshi; 2003 May; 92(5):877-83. PubMed ID: 12808915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.